Pfizer inks $43 billion Seagen deal to boost cancer portfolio

Pfizer buys Seagen Inc. for $43 bln, boosts access to cancer drugs

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.The

Pfizer buys Seagen for $43B, boosts access to cancer drugs

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.

Pfizer buys Seagen for $43B, boosts access to cancer drugs | Chattanooga Times Free Press

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.

Pfizer buys Seagen for $43B, boosts access to cancer drugs

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.

Pfizer buys biotech firm Seagen for $43 billion

WASHINGTON: US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.Pfizer is offering...

Pfizer buys Seagen for 43 billion dollars: it is a leader in cancer treatments

The American pharmaceutical giant will pay 229 dollars in cash for each share. The agreement will be finalized between the end of 2023 and the beginning of 2024